155 related articles for article (PubMed ID: 6540539)
1. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL
Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539
[TBL] [Abstract][Full Text] [Related]
2. The role of fibrinolysis in the therapy of peripheral vascular disease.
Ambrus CM; Ambrus JL; Gastpar H; Sharma SD; Suh OW; Moore RH; Williams P
Angiology; 1984 Jul; 35(7):436-42. PubMed ID: 6235758
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
Strano A; Davi G; Avellone G; Novo S; Pinto A
Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
[TBL] [Abstract][Full Text] [Related]
5. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
Perego MA; Sergio G; Artale F; Giunti P; Danese C
Curr Med Res Opin; 1986; 10(2):135-8. PubMed ID: 3709212
[TBL] [Abstract][Full Text] [Related]
6. Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.
Accetto B
Am Heart J; 1982 May; 103(5):864-9. PubMed ID: 7041579
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
8. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
Angelkort B
Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
[No Abstract] [Full Text] [Related]
9. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ
Angiology; 1989 Jul; 40(7):639-49. PubMed ID: 2662830
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline -- a biomedical profile.
Müller R
J Med; 1979; 10(5):307-29. PubMed ID: 393789
[TBL] [Abstract][Full Text] [Related]
11. Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches.
Ambrus JL; Ambrus CM; Taheri SA; Gastpar H; Reddington MM; Taheri P; Kahn EA; Schattman GL; Dean LS; Moore RH
Angiology; 1984 Jul; 35(7):418-26. PubMed ID: 6540538
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
[TBL] [Abstract][Full Text] [Related]
14. Hemorheology in surgery--a review.
Müller R; Musikić P
Angiology; 1987 Aug; 38(8):581-92. PubMed ID: 3307545
[TBL] [Abstract][Full Text] [Related]
15. Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
Ehrly AM; Saeger-Lorenz K
Angiology; 1987 Feb; 38(2 Pt 1):93-100. PubMed ID: 3548493
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Angelkort B; Doppelfeld E
Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
[TBL] [Abstract][Full Text] [Related]
17. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis.
Ambrus JL; Ambrus CM; Sharma SD; Suh OW; Gastpar H
J Med; 1982; 13(5-6):365-71. PubMed ID: 6221055
[TBL] [Abstract][Full Text] [Related]
18. Blood flow properties and walking performance in chronic arterial occlusive disease.
Angelkort B; Spürk P; Habbaba A; Mähder M
Angiology; 1985 May; 36(5):285-92. PubMed ID: 3896044
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Schweiger H; Ortmeier CJ
Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
Zaccaria A; Antonini M; Marciani A; Taurino M; Speziale F; Spartera C
Ric Clin Lab; 1981; 11 Suppl 1():381-6. PubMed ID: 7188126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
